Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Killed by leukocytes that don't know when to leave

Patients with severe asthma accumulate inflammatory cells in their airway walls. Studies with MMP2-deficient mice now show that an inability of these cells to egress from the lung can be fatal.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Genetic deletion or pharmacologic blockade of MMP2 inhibits the movement of leukocytes from the airway stromal compartment to the airway lumen.

Bob Crimi

References

  1. Molfino, N. A., Nannini, L. J., Martelli, A. N. & Slutsky, A. S. N. Engl. J. Med. 324, 285–288 (1991).

    Article  CAS  Google Scholar 

  2. Dunhill, M. J. Clin. Pathol. 13, 27–33 (1960).

    Article  Google Scholar 

  3. Corry, D. B. et al. Nature Immunol. 3, '‐' (2002). (CASEY – add pages, this is Corry)

  4. Rossi, D. & Zlotnik, A. Annu. Rev. Immunol. 18, 217–242 (2000).

    Article  CAS  Google Scholar 

  5. Yamaguchi, Y. et al. J. Exp. Med. 167, 1737–1742 (1988).

    Article  CAS  Google Scholar 

  6. Zhou, Z. et al. Proc. Natl Acad. Sci. USA 97, 4052–4057 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheppard, D. Killed by leukocytes that don't know when to leave. Nat Immunol 3, 337–338 (2002). https://doi.org/10.1038/ni0402-337

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni0402-337

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing